Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
CD
Cardlytics, Inc. Common Stock
CDLX
Mkt Cap
$11.9M
Volume
188.06K
Next Earnings
November 4th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
CD
CDLX
CD
Cardlytics, Inc. Common Stock
CDLX
News
·
Cardlytics (CDLX) Q2 Users Jump 19%
Mkt Cap
$12.1M
Volume
188.06K
Next Earnings
November 4th
Chart
Financials
Earnings
News
About
Insider
Filings
Cardlytics (CDLX) Q2 Users Jump 19%
Cardlytics reported mixed Q2 2025 results with declining revenue but improved earnings, highlighting challenges in monetizing its growing user base while expanding partnerships beyond traditional banking channels.
The Motley Fool · Aug 7, 2025
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
Cardlytics, Inc. is facing a federal securities class action lawsuit due to alleged false and/or misleading statements about its financial performance and business prospects.
GlobeNewswire Inc. · Mar 15, 2025
CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
A class action lawsuit has been filed against Cardlytics, Inc. (CDLX) for alleged violations of federal securities laws. The lawsuit claims the company made materially false and/or misleading statements about its business, operations, and prospects during the class period.
GlobeNewswire Inc. · Feb 21, 2025
Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections – Hagens Berman
Cardlytics, an advertising technology company, is facing a class-action lawsuit alleging that it misled investors about its growth prospects. The lawsuit claims the company made false or misleading statements and failed to disclose key information about its business, leading to significant stock price drops.
GlobeNewswire Inc. · Feb 14, 2025
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Cardlytics, Inc. (NASDAQ: CDLX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel
A class action lawsuit has been filed against Cardlytics, Inc. (NASDAQ: CDLX) for allegedly making materially misleading statements about its business, operations, and prospects during the class period from March 14, 2024 to August 7, 2024.
GlobeNewswire Inc. · Feb 13, 2025
Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections – Hagens Berman
Cardlytics, an advertising technology company, is facing a class-action lawsuit alleging that it misled investors about its growth prospects. The lawsuit claims that Cardlytics made false and misleading statements about the impact of increased consumer engagement on its financial performance, leading to significant stock drops.
GlobeNewswire Inc. · Feb 13, 2025
Cardlytics, Inc. Shareholders with Large Losses Should Contact Robbins LLP for Information About the CDLX Class Action Lawsuit
Cardlytics, Inc. is facing a class action lawsuit alleging that the company misled investors about its business prospects, leading to a significant drop in its stock price.
GlobeNewswire Inc. · Feb 12, 2025
Class Action Filed Against Cardlytics, Inc. (CDLX) - March 25, 2025 Deadline to Join – Contact The Gross Law Firm
A class action lawsuit has been filed against Cardlytics, Inc. (CDLX) for allegedly issuing materially false and/or misleading statements during the class period of March 14, 2024 to August 7, 2024. The lawsuit claims that the company's positive statements about its business, operations, and prospects were misleading.
GlobeNewswire Inc. · Feb 6, 2025
CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
A class action lawsuit has been filed against Cardlytics, Inc. (CDLX) for alleged violations of federal securities laws. The lawsuit claims the company made materially false and/or misleading statements about its business, operations, and prospects during the class period.
GlobeNewswire Inc. · Feb 4, 2025
Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections – Hagens Berman
Cardlytics, an advertising technology company, is facing a class-action lawsuit alleging that it misled investors about its growth prospects. The lawsuit claims the company made false or misleading statements and failed to disclose key information about its business, leading to significant stock price drops.
GlobeNewswire Inc. · Jan 29, 2025
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
CD
CDLX
Cardlytics, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
CDLX
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any CDLX yet.
Related Tickers
Earnings